Conditioned Medium - Is it an Undervalued Lab Waste with the Potential for Osteoarthritis Management?

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Current osteoarthritis (OA) treatments offer short-term relief with limited success.
• Cell-based therapies for OA face challenges including source variability, side effects, and stringent protocols.
• Underexplored stromal cell secretomes possess protective and anti-aging properties beneficial for OA.

Purpose of the Study:

• To review the advantages of conditioned media (CM) and exosomes over traditional cell-based therapies for OA.
• To summarize the composition of CM derived from mesenchymal stromal cells (MSCs).
• To analyze the effects of CM on chondrocytes in the context of OA.

Main Methods:

• Literature review of studies on MSC-conditioned media and exosomes.
• Analysis of the composition of CM from various MSC sources (adipose, bone marrow, umbilical cord).
• Examination of in vitro and in vivo data on CM effects on chondrocytes and OA pathomechanisms.

Main Results:

• MSC-conditioned media contain proteins, cytokines, growth factors, and ncRNAs with diverse functions.
• CM from MSCs demonstrated beneficial effects in enhancing processes related to chondrocyte OA pathomechanism in most studies.
• Exosomes within CM also contribute to therapeutic potential.

Conclusions:

• Conditioned media (CM) and exosomes from mesenchymal stromal cells (MSCs) show superiority over other cell-based methods for OA.
• Standardization of CM production protocols is crucial for clinical translation.
• Further clinical trials are needed to validate the in vitro efficacy of CM in human subjects.